Barry G Fields1,2, Pratima Pathak Behari3,4,5, Susan McCloskey3, Gala True3, Diane Richardson3, Arwin Thomasson3,6, Danijela Korom-Djakovic3,7, Keith Davies3, Samuel T Kuna3,4,5. 1. Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University, Atlanta, GA. 2. Atlanta Veterans Affairs Medical Center, Decatur, GA. 3. Philadelphia Veterans Affairs Medical Center, Philadelphia, PA. 4. Division of Sleep Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 5. Center for Sleep and Circadian Neurobiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 6. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 7. Independent Researcher, Philadelphia, PA.
Abstract
STUDY OBJECTIVES: Despite significant medical sequelae of obstructive sleep apnea (OSA), the condition remains undiagnosed and untreated in many affected individuals. We explored the feasibility of a comprehensive, telemedicine-based OSA management pathway in a community-based Veteran cohort. METHODS: This prospective, parallel-group randomized pilot study assessed feasibility of a telemedicine-based pathway for OSA evaluation and management in comparison to a more traditional, in-person care model. The study included 60 Veterans at the Philadelphia Veterans Affairs Medical Center and two affiliated community-based outpatient clinics. Telemedicine pathway feasibility, acceptability, and outcomes were assessed through a variety of quantitative (Functional Outcomes of Sleep Questionnaire, dropout rates, positive airway pressure [PAP] adherence rates, participant satisfaction ratings) and qualitative (verbal feedback) metrics. RESULTS: There was no significant difference in functional outcome changes, patient satisfaction, dropout rates, or objectively measured PAP adherence between groups after 3 months of treatment. Telemedicine participants showed greater improvement in mental health scores, and their feedback was overwhelmingly positive. CONCLUSIONS: Our pilot study suggests that telemedicine-based management of OSA patients is feasible in terms of patient functional outcomes and overall satisfaction with care. Future studies should include larger populations to further elucidate these findings while assessing provider- and patient-related cost effectiveness.
RCT Entities:
STUDY OBJECTIVES: Despite significant medical sequelae of obstructive sleep apnea (OSA), the condition remains undiagnosed and untreated in many affected individuals. We explored the feasibility of a comprehensive, telemedicine-based OSA management pathway in a community-based Veteran cohort. METHODS: This prospective, parallel-group randomized pilot study assessed feasibility of a telemedicine-based pathway for OSA evaluation and management in comparison to a more traditional, in-person care model. The study included 60 Veterans at the Philadelphia Veterans Affairs Medical Center and two affiliated community-based outpatient clinics. Telemedicine pathway feasibility, acceptability, and outcomes were assessed through a variety of quantitative (Functional Outcomes of Sleep Questionnaire, dropout rates, positive airway pressure [PAP] adherence rates, participant satisfaction ratings) and qualitative (verbal feedback) metrics. RESULTS: There was no significant difference in functional outcome changes, patient satisfaction, dropout rates, or objectively measured PAP adherence between groups after 3 months of treatment. Telemedicine participants showed greater improvement in mental health scores, and their feedback was overwhelmingly positive. CONCLUSIONS: Our pilot study suggests that telemedicine-based management of OSA patients is feasible in terms of patient functional outcomes and overall satisfaction with care. Future studies should include larger populations to further elucidate these findings while assessing provider- and patient-related cost effectiveness.
Authors: Carol E Smith; Emily R Dauz; Faye Clements; Florence N Puno; David Cook; Gary Doolittle; William Leeds Journal: Telemed J E Health Date: 2006-06 Impact factor: 3.536
Authors: Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver Journal: Sleep Med Rev Date: 2011-06-08 Impact factor: 11.609
Authors: Manisha B Witmans; Bruce Dick; Jackie Good; Greg Schoepp; Cara Dosman; Mary Ellen Hawkins; Rochelle Young; Adrienne Witol Journal: Behav Sleep Med Date: 2008 Impact factor: 2.964
Authors: Terri E Weaver; Cristina Mancini; Greg Maislin; Jacqueline Cater; Bethany Staley; J Richard Landis; Kathleen A Ferguson; Charles F P George; David A Schulman; Harly Greenberg; David M Rapoport; Joyce A Walsleben; Teofilo Lee-Chiong; Indira Gurubhagavatula; Samuel T Kuna Journal: Am J Respir Crit Care Med Date: 2012-07-26 Impact factor: 21.405
Authors: Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack Journal: Sleep Date: 2007-06 Impact factor: 5.849
Authors: Kathleen F Sarmiento; Robert L Folmer; Carl J Stepnowsky; Mary A Whooley; Eilis A Boudreau; Samuel T Kuna; Charles W Atwood; Connor J Smith; W Claibe Yarbrough Journal: J Clin Sleep Med Date: 2019-09-15 Impact factor: 4.062
Authors: Lucas M Donovan; Aditi Shah; Ching Li Chai-Coetzer; Ferran Barbé; Najib T Ayas; Vishesh K Kapur Journal: Chest Date: 2019-10-19 Impact factor: 9.410
Authors: Qurratul Afifa Shamim-Uzzaman; Charles J Bae; Zarmina Ehsan; Arveity R Setty; Michelle Devine; Swati Dhankikar; Innessa Donskoy; Barry Fields; Hunter Hearn; Dennis Hwang; Vikas Jain; Dennis Kelley; Douglas B Kirsch; William Martin; Matthew Troester; Lynn Marie Trotti; Christine H Won; Lawrence J Epstein Journal: J Clin Sleep Med Date: 2021-05-01 Impact factor: 4.062